DocuSign Insider Mary Agnes Wilderotter Swaps 3,000 Shares in Quiet, Long‑Term Buy‑Sell Cycle as Executives Offload Stocks in Routine 10‑b‑5‑1 Deals

Insider Activity Spotlight: DocuSign’s Latest Dealings

Current Transaction Overview On April 1, 2026, Mary Agnes Wilderotter bought 3,000 shares of DocuSign common stock at the prevailing market price of $48.37, while simultaneously selling 3,000 shares and exercising a stock‑option sale. The net result was a modest increase in her holdings to 62,803 shares. The trade executed at a time of relatively low social‑media buzz (11.44 %) and neutral sentiment, suggesting that Wilderotter’s purchase was not driven by a sudden market‑moving event but rather by a planned investment strategy.

Implications for Investors The buying‑selling pattern exhibited by Wilderotter aligns with the broader insider trend observed in early April: several senior executives, including the President‑CEO and the Chief Revenue Officer, were liquidating large blocks of common stock. These sales are consistent with routine “10‑b‑5‑1” arrangements that allow insiders to sell shares without impacting market liquidity. For investors, the key takeaway is that the sell‑side activity is largely pre‑planned and not an immediate signal of management’s confidence in short‑term growth. Instead, the purchase by Wilderotter—who has a history of alternating between restricted‑stock and common‑stock transactions—may indicate a long‑term stake held with a view to benefit from DocuSign’s continued expansion in the e‑signature and workflow market.

Analyzing Wilderotter’s Trading Profile Wilderotter’s transaction history shows a pattern of disciplined trading: she alternates between buying and selling 729‑share blocks of common stock and restricted‑stock units, with occasional option sales. Over the past year, her net holdings have fluctuated between 59,074 and 62,803 shares, reflecting a steady, moderate exposure. The recent purchase of 3,000 shares—roughly 5 % of her current position—does not dramatically alter her exposure but does suggest a confidence in DocuSign’s valuation, given the share price’s upward trajectory (year‑to‑date gain of over 1,100 %).

What This Means for DocuSign’s Future DocuSign’s fundamentals remain robust, with a market cap of $9.37 billion and a P/E ratio of 32.44. The company’s platform continues to dominate the e‑signature space, and its expansion into workflow automation positions it for sustained revenue growth. Insider sell‑side activity, while notable, is routine and does not necessarily foreshadow a decline. Investors should focus on the company’s quarterly earnings guidance, product pipeline, and competitive positioning. Wilderotter’s purchase may be viewed as a subtle endorsement of the company’s long‑term prospects, offering a small boost of confidence for those evaluating a mid‑ to long‑term investment horizon.